Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism β3-adrenergic receptor agonists(Beta-3 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20ClNNa2O7 |
InChIKeyUVJBVPHQFYWKJL-CFOQQKEYSA-N |
CAS Registry138908-40-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | EU | - | - |
Diabetes Mellitus, Type 2 | Phase 2 | US | - | |
Diabetes Mellitus, Type 2 | Phase 2 | - | - | |
Obesity | Phase 2 | - | - | |
Obesity | Phase 2 | EU | - | - |
Obesity | Phase 2 | US | - | |
Urinary Bladder, Overactive | Phase 2 | US | - |
Not Applicable | - | - | uugwmlfkhw(uflbfrastd) = trvwbqzcsa fifbncxqdf (jxfhldqkld ) View more | - | 01 Apr 2012 |